Media

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations...
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and...

Press Releases

Feb 14 2003
WASHINGTON, D.C. (February 14, 2003) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today issued the following statement...
Feb 12 2003
WASHINGTON, D.C. (February 12, 2003) --- In recognition of biotechnology corporate excellence, the eighth annual Helix Award will be presented to three...
Feb 11 2003
WASHINGTON, D.C. (February 11, 2003)—The Biotechnology Industry Organization (BIO) today announced an array of industry experts that will discuss the future of...
Feb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following...
Feb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following...
Feb 4 2003
WASHINGTON, D.C. (February 4, 2003) - The Biotechnology Industry Organization (BIO) will host its fifth annual CEO & Investor Conference February 25-27 at...
Jan 29 2003
WASHINGTON, D.C. (January 29, 2003) – Richard F. Pops, CEO of Alkermes, Inc., and vice-chair of healthcare for the Biotechnology Industry Organization...
Jan 29 2003
Washington, D.C. (January 29, 2003) − Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in...
Jan 28 2003
WASHINGTON, D.C. (January 28, 2003) — Media registration is now open for the Biotechnology Industry Organization’s (BIO) CEO & Investor Conference 2003,...